Physician profile
Erin Smith
NPI 1346503109
$8,147.01
in general payments reported to CMS, 2019-2025
35 companies · $1,467 in 2025
The $1,467 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $881 · 2023: $1,905 · 2024: $2,755 · 2025: $1,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,196 · Food and Beverage: $1,730 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,195.72 |
| Food and Beverage | $1,730.33 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $4,405.84 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $689.69 | 2021-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $497.53 | 2021-2025 | |
| Abbvie INC. | $410.89 | 2021-2023 | |
| Myovant Sciences INC. | $339.69 | 2021-2022 | |
| Pfizer INC. | $239.15 | 2021-2024 | |
| Exeltis, USA INC. | $139.62 | 2021-2023 | Slynd |
| Lantheus Medical Imaging, INC. | $116.30 | 2025 | |
| Corcept Therapeutics | $115.26 | 2021-2024 | Korlym |
| Exact Sciences Corporation | $113.54 | 2023-2024 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $111.95 | 2021-2023 | Twirla |
| Amgen INC. | $89.38 | 2021-2023 | Prolia, Evenity |
| Medtronic, INC. | $88.67 | 2024-2025 | Interstim |
| Evofem Biosciences, INC. | $86.38 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $67.69 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $61.40 | 2022 | |
| Sumitomo Pharma America, INC. | $61.16 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $53.22 | 2021-2024 | Ova1 |
| Channel Medsystems, INC. | $48.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.08 | 2021-2025 | |
| Therapeuticsmd, INC. | $39.67 | 2021 | |
| Scynexis, INC. | $36.95 | 2022 | |
| Neurocrine Biosciences, INC. | $34.19 | 2025 | |
| Boston Scientific Corporation | $28.63 | 2024 | Advantage System |
| Baxter Healthcare | $27.85 | 2025 | Coseal |
| Gynesonics, INC. | $26.43 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $26.30 | 2024 | Zilretta, Iovera, Exparel |
| Glaxosmithkline, LLC. | $21.77 | 2021 | |
| Becton, Dickinson and Company | $21.69 | 2024 | |
| Hologic Sales and Service, LLC | $21.07 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Axonics, INC. | $20.65 | 2022 | |
| Millicent US INC | $19.21 | 2024 | Intrarosa |
| Merck Sharp & Dohme LLC | $15.37 | 2021 | |
| Biogen, INC. | $13.64 | 2024 | |
| Convatec INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.